New Two-Pronged attack on rare head and neck cancer
Disease control
Recruiting now
This study is testing a combination of two drugs for advanced salivary gland cancer that has spread or returned and cannot be treated with surgery or radiation. The treatment pairs a hormone-blocking therapy (ADT) with an immunotherapy drug (pembrolizumab) to see if they work bet…
Phase: PHASE2 • Sponsor: Manish Patel • Aim: Disease control
Last updated Apr 13, 2026 20:18 UTC